Androgen therapy in hypogonadal adolescent males

Silvano Bertelloni, Giampiero I. Baroncelli, Piernicola Garofalo, Stefano Cianfarani

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Androgen treatment represents a main aspect of clinical management of boys with hypogonadism from adolescence onwards. Androgen replacement therapy is required to induce secondary sexual characteristics and adult male body composition, to optimize the accrual of bone mineral content and muscle mass, and to promote physical and social well-being. Testosterone is the only sex steroid hormone suitable for treatment in hypogonadal boys as it fulfils all the physiological requirements. However, the optimal regimens for androgen replacement therapy during adolescence remain to be defined. The new testosterone formulations (patch, gel, transbuccal and long-acting) have been designed for use in adults and the available dosages are probably too high to induce and manage puberty in adolescents properly. The aim of this paper is to provide practical indications for androgen treatment in male adolescents with hypogonadism.

Original languageEnglish
Pages (from-to)292-296
Number of pages5
JournalHormone Research in Paediatrics
Volume74
Issue number4
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Androgens
Hypogonadism
Testosterone
Therapeutics
Gonadal Steroid Hormones
Puberty
Body Composition
Bone Density
Gels
Muscles

Keywords

  • Adolescence
  • Androgen replacement therapy
  • Delayed puberty
  • Hypogonadism
  • Testosterone

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

Androgen therapy in hypogonadal adolescent males. / Bertelloni, Silvano; Baroncelli, Giampiero I.; Garofalo, Piernicola; Cianfarani, Stefano.

In: Hormone Research in Paediatrics, Vol. 74, No. 4, 10.2010, p. 292-296.

Research output: Contribution to journalArticle

Bertelloni, Silvano ; Baroncelli, Giampiero I. ; Garofalo, Piernicola ; Cianfarani, Stefano. / Androgen therapy in hypogonadal adolescent males. In: Hormone Research in Paediatrics. 2010 ; Vol. 74, No. 4. pp. 292-296.
@article{d2222db61ce54e4986b8ae63b3acebf2,
title = "Androgen therapy in hypogonadal adolescent males",
abstract = "Androgen treatment represents a main aspect of clinical management of boys with hypogonadism from adolescence onwards. Androgen replacement therapy is required to induce secondary sexual characteristics and adult male body composition, to optimize the accrual of bone mineral content and muscle mass, and to promote physical and social well-being. Testosterone is the only sex steroid hormone suitable for treatment in hypogonadal boys as it fulfils all the physiological requirements. However, the optimal regimens for androgen replacement therapy during adolescence remain to be defined. The new testosterone formulations (patch, gel, transbuccal and long-acting) have been designed for use in adults and the available dosages are probably too high to induce and manage puberty in adolescents properly. The aim of this paper is to provide practical indications for androgen treatment in male adolescents with hypogonadism.",
keywords = "Adolescence, Androgen replacement therapy, Delayed puberty, Hypogonadism, Testosterone",
author = "Silvano Bertelloni and Baroncelli, {Giampiero I.} and Piernicola Garofalo and Stefano Cianfarani",
year = "2010",
month = "10",
doi = "10.1159/000320390",
language = "English",
volume = "74",
pages = "292--296",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Androgen therapy in hypogonadal adolescent males

AU - Bertelloni, Silvano

AU - Baroncelli, Giampiero I.

AU - Garofalo, Piernicola

AU - Cianfarani, Stefano

PY - 2010/10

Y1 - 2010/10

N2 - Androgen treatment represents a main aspect of clinical management of boys with hypogonadism from adolescence onwards. Androgen replacement therapy is required to induce secondary sexual characteristics and adult male body composition, to optimize the accrual of bone mineral content and muscle mass, and to promote physical and social well-being. Testosterone is the only sex steroid hormone suitable for treatment in hypogonadal boys as it fulfils all the physiological requirements. However, the optimal regimens for androgen replacement therapy during adolescence remain to be defined. The new testosterone formulations (patch, gel, transbuccal and long-acting) have been designed for use in adults and the available dosages are probably too high to induce and manage puberty in adolescents properly. The aim of this paper is to provide practical indications for androgen treatment in male adolescents with hypogonadism.

AB - Androgen treatment represents a main aspect of clinical management of boys with hypogonadism from adolescence onwards. Androgen replacement therapy is required to induce secondary sexual characteristics and adult male body composition, to optimize the accrual of bone mineral content and muscle mass, and to promote physical and social well-being. Testosterone is the only sex steroid hormone suitable for treatment in hypogonadal boys as it fulfils all the physiological requirements. However, the optimal regimens for androgen replacement therapy during adolescence remain to be defined. The new testosterone formulations (patch, gel, transbuccal and long-acting) have been designed for use in adults and the available dosages are probably too high to induce and manage puberty in adolescents properly. The aim of this paper is to provide practical indications for androgen treatment in male adolescents with hypogonadism.

KW - Adolescence

KW - Androgen replacement therapy

KW - Delayed puberty

KW - Hypogonadism

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=77958034175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958034175&partnerID=8YFLogxK

U2 - 10.1159/000320390

DO - 10.1159/000320390

M3 - Article

VL - 74

SP - 292

EP - 296

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 4

ER -